The performance of some home testing kits for COVID-19 appears to have declined as the omicron variant emerged, suggests a study published by The BMJ today.
Sep 14, 2022
0
200
The prostate-specific antigen test for prostate cancer was developed in the 1990s, quickly followed by an explosion of PSA screening for the disease and a further explosion of treatment. Treatment consists of either radiation ...
Sep 26, 2016
0
21
Rapid Covid home tests are more likely to give a false negative with the heavily-mutated Omicron variant compared to earlier strains, the US Food and Drug Administration (FDA) said Tuesday.
Dec 29, 2021
0
14
Infectious mononucleosis, or mono, sidelines high school athletes every year. Kids who play sports aren't more susceptible to the disease. Instead, adolescent competitors are at a greater risk for one of the illness's serious ...
Apr 5, 2019
0
6
More than two years since the COVID-19 global pandemic began, the SARS-CoV-2 virus continues its rampage through rapidly evolving mutations and gaps in population immunity. But the outlook for managing COVID-19 is brighter ...
Jun 15, 2022
0
21
Men ages 55 to 69 should talk with their health care provider about prostate-specific antigen (PSA)-based screening for prostate cancer. That's according to new recommendations from the U.S. Preventive Services Task Force.
Apr 17, 2017
0
4
CAR T-cell therapy, a certain kind of cancer treatment in which the immune system's T cells are programmed to attack tumor cells, is effective in mice with ovarian cancer, according to a study published in The Journal for ...
Feb 6, 2023
0
17
A new test for prostate cancer that measures levels of prostate specific antigen (PSA) as well as six specific antibodies found in the blood of men with the disease was more sensitive and more specific than the conventional ...
May 16, 2011
0
0
"COVID rebound," in which evidence of the illness disappears and then returns days or weeks later, is surprisingly common—whether or not patients are given the antiviral Paxlovid.
Mar 3, 2023
0
48
Alberta men with elevated prostate-specific antigen (PSA) levels can now take a new blood test to determine their risk for clinically significant prostate cancer and potentially avoid an unnecessary biopsy.
Oct 6, 2023
0
30
